top of page

Our Capabilities

  • We facilitate Western companies in accessing globally competitive pharmaceutical assets in Asia, particularly in China, and providing unparalleled market insights and strategic entry points.

  • We support Asian companies, especially those with robust R&D or investment ties to the Chinese biotech sector, to connect with Western biopharma, biotech, and life sciences investment firms, to conduct BD&L, NewCo formation, R&D collaboration, and other strategic collaborations.​

  • We offer expert consultation to global companies, enabling them to leverage the booming Asian biotech industry to stay ahead in business development, R&D, portfolio management, fundraising, and go-to-market strategies, ensuring sustainable competitiveness and innovation.

bottom of page